Neogen Corp (NASDAQ:NEOG)
| 71.36 BATS BZX Real-Time Price As of 2:16pm ET |  +0.99 / +1.41%Today’s Change | 48.91 Today|||52-Week Range 82.06 | +9.35% Year-to-Date |
Latest NEOG News | Press Releases
| Neogen (NEOG) Down 5.8% Since Last Earnings Report: Can It Rebound? 11:30am / Zacks.com - Paid Partner Content | Should You Invest in the Invesco SP SmallCap Health Care ETF (PSCH)? Oct 16 / Zacks.com - Paid Partner Content |
| These Surface Disinfectant Stocks Have Strong Upside Potential Oct 16 / GuruFocus News - Paid Partner Content |
Today’s Trading
| Previous close | 70.37 |
| Today’s open | 70.42 |
| Day’s range | 70.46 - 71.43 |
| Volume | 3,445 |
| Average volume (3 months) | 358,208 |
| Market cap | $3.8B |
Data as of 2:16pm ET, 10/22/2020
Growth & Valuation
| Earnings growth (last year) | -2.41% |
| Earnings growth (this year) | +7.96% |
| Earnings growth (next 5 years) | +10.00% |
| Revenue growth (last year) | +0.96% |
| P/E ratio | 62.1 |
| Price/Sales | 9.00 |
| Price/Book | 5.22 |
Competitors
| Today’s change | Today’s % change | |
|---|---|---|
| CDNACareDx Inc | +1.22 | +2.46% |
| VCYTVeracyte Inc | +0.74 | +1.87% |
| TRILTrillium Therapeutic... | +0.03 | +0.23% |
| MYGNMyriad Genetics Inc | +0.53 | +3.78% |
Data as of 2:21pm ET, 10/22/2020
Financials
| Next reporting date | December 17, 2020 |
| EPS forecast (this quarter) | $0.32 |
| Annual revenue (last year) | $418.2M |
| Annual profit (last year) | $59.5M |
| Net profit margin | 14.22% |
Profile
Sector Health Technology |
Industry Medical Specialties |
No executives to display |
Corporate headquarters Lansing, Michigan |
Forecasts
